Skip to main content
TipRanks
Go Ultimate75% OFF

Caliway Biopharmaceuticals Co Ltd (6919) Balance Sheet

Caliway Biopharmaceuticals Co Ltd Balance Sheet

Caliway Biopharmaceuticals Co Ltd's total assets for Q2 2026 were NT$9.43B, a decrease of 1.11% from the previous quarter. TW:6919 total liabilities were NT$223.88M for the fiscal quarter, a 28.82% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 301.89MNT$ 9.77BNT$ 3.83BNT$ 1.23BNT$ 711.96M
NT$ 2.03MNT$ 73.69MNT$ 85.55MNT$ 68.82MNT$ 68.15M
NT$ 299.86MNT$ 9.70BNT$ 3.74BNT$ 1.16BNT$ 643.81M

Currency in TWD

Caliway Biopharmaceuticals Co Ltd Liabilities to Assets

04B8B12B0 %40 %80 %120 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets